1. Home
  2. TURN vs LTRN Comparison

TURN vs LTRN Comparison

Compare TURN & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TURN
  • LTRN
  • Stock Information
  • Founded
  • TURN 1981
  • LTRN 2013
  • Country
  • TURN United States
  • LTRN United States
  • Employees
  • TURN N/A
  • LTRN N/A
  • Industry
  • TURN Finance/Investors Services
  • LTRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TURN Finance
  • LTRN Health Care
  • Exchange
  • TURN Nasdaq
  • LTRN Nasdaq
  • Market Cap
  • TURN 39.6M
  • LTRN 33.7M
  • IPO Year
  • TURN N/A
  • LTRN 2020
  • Fundamental
  • Price
  • TURN $4.12
  • LTRN $5.01
  • Analyst Decision
  • TURN
  • LTRN Hold
  • Analyst Count
  • TURN 0
  • LTRN 1
  • Target Price
  • TURN N/A
  • LTRN N/A
  • AVG Volume (30 Days)
  • TURN 48.0K
  • LTRN 167.8K
  • Earning Date
  • TURN 02-25-2025
  • LTRN 03-17-2025
  • Dividend Yield
  • TURN N/A
  • LTRN N/A
  • EPS Growth
  • TURN N/A
  • LTRN N/A
  • EPS
  • TURN N/A
  • LTRN N/A
  • Revenue
  • TURN $129,297.00
  • LTRN N/A
  • Revenue This Year
  • TURN N/A
  • LTRN N/A
  • Revenue Next Year
  • TURN N/A
  • LTRN N/A
  • P/E Ratio
  • TURN N/A
  • LTRN N/A
  • Revenue Growth
  • TURN 6.32
  • LTRN N/A
  • 52 Week Low
  • TURN $3.12
  • LTRN $2.79
  • 52 Week High
  • TURN $4.47
  • LTRN $11.99
  • Technical
  • Relative Strength Index (RSI)
  • TURN 66.26
  • LTRN 58.38
  • Support Level
  • TURN $3.85
  • LTRN $4.50
  • Resistance Level
  • TURN $4.05
  • LTRN $5.70
  • Average True Range (ATR)
  • TURN 0.13
  • LTRN 0.47
  • MACD
  • TURN 0.00
  • LTRN -0.03
  • Stochastic Oscillator
  • TURN 95.71
  • LTRN 49.26

About TURN 180 Degree Capital Corp.

180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: